Patents/Inventors

Gregory Moore

Azusa, CAUS22 patents

23 Patents

US124484232025
Targeted Heterodimeric Fc Fusion Proteins Containing NKG2D Antigen Binding Domains
Xencor, Inc.
0 cites
US124158492025
Heterodimeric Proteins
Xencor, Inc.
0 cites
US123783132025
Bispecific Binding Agents Binding to CLDN18.2 and CD3
Xencor, Inc.
0 cites
US123783262025
Anti-cd28 X Anti-psma Antibodies
Xencor, Inc.
0 cites
US123657432025
Anti-cd28 X Anti-psma Antibodies
Xencor, Inc.
0 cites
US123590022025
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US121520762024
Bispecific and Monospecific Antibodies Using Novel Anti-pd-1 Sequences
Xencor, Inc.
0 cites
US121479602024
Systems and Methods for Mobile Point-of-sale Transactions
SHOPIFY Inc.
0 cites
US121293092024
Heterodimeric Antibodies That Bind CD3 and CD38
Xencor, Inc.
0 cites
US120545452024
Heterodimeric Antibodies That Bind Somatostatin Receptor 2
Xencor, Inc.
0 cites
US120063452024
Untargeted and Targeted IL-10 Fc-fusion Proteins
Xencor, Inc.
0 cites
US119458802024
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US119199582024
Anti-cd28 Compositions
Xencor, Inc.
0 cites
US118590112024
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US118405792023
Bispecific Antibodies That Bind to CD38 and CD3
Xencor, Inc.
0 cites
US118144232023
Heterodimeric Proteins
Xencor, Inc.
0 cites
US117391452023
Bispecific Binding Agents Binding to CLDN18.2 and CD3
0 cites
US117186672023
Optimized Antibody Variable Regions
Xencor, Inc.
0 cites
US116739722023
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US116345062023
Heterodimeric Proteins
Xencor, Inc.
0 cites
US116239572023
Heterodimeric Antibodies That Bind CD3 and PSMA
Xencor, Inc.
0 cites
US116187762023
Targeted Heterodimeric Fc Fusion Proteins Containing IL-15/IL-15RA and NKG2D Antigen Binding Domains
Xencor, Inc.
0 cites
US115914012023
Anti-cd28 Compositions
Xencor, Inc.
0 cites